Wealthcare Advisory Partners’s Zosano Pharma Corporation ZSAN Stock Holding History

Wealthcare Advisory Partners’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-897	Closed	-$7K	–	625
2022 Q1	$7K	Hold	897	–	–	﹤0.01%	540
2021 Q4	$15K	Hold	897	–	–	﹤0.01%	573
2021 Q3	$23K	Sell	897 -114	-11%	-$2.96K	﹤0.01%	544
2021 Q2	$34K	Hold	1,011	–	–	﹤0.01%	551
2021 Q1	$44K	Sell	1,011 -953	-49%	-$39.9K	﹤0.01%	919
2020 Q4	$36K	Buy	1,964 +1,095	+126%	+$21.4K	﹤0.01%	431
2020 Q3	$49K	Buy	869 +526	+153%	+$24.5K	0.01%	358
2020 Q2	$10K	Buy	+343	New	+$9.69K	﹤0.01%	319

Other funds holding ZSAN

CDIA

Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Wealthcare Advisory Partners's ZSAN Position: Q2 2022 in Review

Wealthcare Advisory Partners sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 897 shares — an estimated $7K sold.

Wealthcare Advisory Partners first reported a position in ZSAN in Q2 2020 and held it in 8 quarters. The position peaked at $49K in Q3 2020. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

Wealthcare Advisory Partners reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
Wealthcare Advisory Partners sold 897 Zosano Pharma Corporation shares in Q2 2022, an estimated $7K.
Wealthcare Advisory Partners first reported a position in Zosano Pharma Corporation in Q2 2020 and held it in 8 quarters.
Wealthcare Advisory Partners's Zosano Pharma Corporation position peaked at $49K in Q3 2020.
3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2022, filed 15 Aug 2022.